Galectin-2 and -4, but not Galectin-1, p
โ
Daniela Paclik; Katrin Lohse; Bertram Wiedenmann; Axel U. Dignass; Andreas Sturm
๐
Article
๐
2008
๐
John Wiley and Sons
๐
English
โ 441 KB
Background: Inflammatory bowel diseases (IBDs) are characterized by various degrees of mucosal surface damage and subsequent impairment of the intestinal barrier function. Resealing of the epithelial barrier requires intestinal cell migration and proliferation. Galectins are increasingly recognized